pharma · Influenza · Encephalitis, Japanese B
Repatha
Repatha is a pharma organization headquartered in JP. Primary therapeutic focus areas include Influenza, Encephalitis, Japanese B, Malaria, Vivax. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 pate
JP HQ
PMDA registrant Type
Company details
- Status
- Public
- HQ
- JP
- Programs
- 3
- Drugs
- 6
- Patents
- 0
primaquine
Approved · small molecule · Malaria, Vivax
primaquine for Malaria, Vivax is a Approved program (small_molecule) at Repatha with 1 ClinicalTrials.gov record(s).
Internal code 856370-2
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Repatha
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Malaria, Vivax
- Status
- terminated
- Trials
- 1